Navigation Links
Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos

A NOVEL research-cum-manufacturing agreement between Chiron Corp, the US-based vaccine major, and an Indian company for the development of a potential AIDS vaccine to halt the spread of the deadly disease in the country is in an advanced stage of finalisation.

Two Hyderabad-based biotechnology/pharma companies -- Shanta Biotechnics and Biological E -- are reportedly the front-runners for the proposed project, which entails an upfront technology transfer fee of $30 million being sought by Chiron Corp, according to industry sources.

The Union Department of Biotechnology (DBT), which received the proposal from Chiron Corp, invited four Indian biotech/pharma companies for discussions towards January-end. These were Ranbaxy Research Laboratories, Serum Institute of India, Shanta Biotechnics and Biological E.

``We are closely examining the proposal made by Chiron Corp as part of our industry-academia initiatives and will take a decision on the Indian partner soon,'' the Secretary of DBT, Dr Manju Sharma, told Business Line.

The DBT expert group on vaccines is looking at the candidate vaccine against AIDS claimed and offered as technology transfer by Chiron Corp. The vaccine is said to be close to being subjected to human trials.

The Managing Director of Shanta Biotechnics (one of the favourites for the collaboration), Mr K. Varaprasada Reddy, confirmed that his company had detailed discussions with Chiron Corp. ``We are willing to take up the project if selected,'' he told Business Line.

Scientists of Chiron Corp including its Chairman had visited the facilities of Shanta Biotechnics during 2000. ``We also have the advantage of possessing recombinant DNA technology for producing vaccines,'' Mr Reddy said.

The collaboration with Chiron Corp would help in giving India a lead of couple of years in the realisation of a viable AIDS vaccine. The funds for carrying out the relevant research and developm
'"/>




Page: 1 2

Related medicine news :

1. Developmental, neurologic problems common in extremely preterm infants
2. Missing Protein In Cancer Development
3. Tomatoes Might Inhibit the Development Of Prostate Cancer
4. Pollution Found To Impair Lung Development
5. Treating Depression In Children Could Lead To Poor Bone Development
6. Developmental Origins of Polycystic Ovarian Syndrome
7. Sleep Not Critical For Early Brain Development Of Baby Dolphins
8. ‘Loud Noise’ Research may help in Development of Prosthetics for Eldery
9. Stop Watching TV: Toddler Development Affected
10. Vitamin Supplements During Pregnancy to Boost Fetal Development
11. Cigarette Smoking Leads To Development Of Type 2 Diabetes In Patients With Coronary Artery Disease

Post Your Comments:
(Date:11/21/2009)..., New Haven Dental Group ...an, D.D.S of Branford, CT. , ...tal Group, comprised of partners Dr. David Gibson,...eph Forrester has just merged their growing practi...ickman., , ,When Dr. Pickman decided he wanted to ...
(Date:11/20/2009)..., , PRINCETON, NJ, Nov. 20 /PRNewswire-Fi... today that a Special Meeting of Shareholders will... of the Meeting is to consider approval of two spe...to approve and authorize the sale of all or substa...y on the terms provided for in the asset purchase ...
(Date:11/20/2009)..., , QUINCY, Mass., Nov. 20 ...p Supermarket Company removed from sale Shedd,s Co...coli Rice and Shedd,s Country Crock ® Side Di... sulfite allergen. ,, The following code dates...ck ® Side Dishes DELUXE Cheddar Broccoli Rice...
(Date:11/20/2009)..., , CHICAGO, Nov. 20 /PRNewswire-USNewswir...asked the U.S. Food and Drug Administration (FDA) ...-whitening chemicals. ,, Citing concern about ...ministered without the benefit of professional con...tion said that the application of chemically based...
(Date:11/20/2009)..., , WINSTON-SALEM, N.C., Nov. 20 /PRNewswi...ut he is on a mission to redefine what it means to...fessional counselor with a specialty in family cou...at Wake Forest University, Gladding says research ...en leads to sadness and even depression during the...
Breaking Medicine News(10 mins):Health News:New Haven Dental Group Expands Their Vision 2Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Why Holidays Don't Have To Be 'Happy' 2
...rs on cells could prompt overeating, study suggest...udy provides more evidence that dopamine -- a brai...ent and motivation -- plays a role in obesity. , R...receptors on brain cells than lean rats. The study...
...owth of Services Revenues, Higher Margins for ...et Results, POWAY, Calif., Oct. 25 Digirad Corpo...ical diagnostic imaging systems,and services to ph...gher revenues, improving gross margins and lower,o...
.... 24 The 5th site in the,AZoNetwork portfolio bui...ials, AZoNano.com - the A to Z of Nanotechnology a...cs.com ( http://www.AZoOptics.com ) is the latest ...h a,continuously updating resource for all the inf...
...The following statement was issued,today by the la... Notice is hereby given that a class action lawsu...or the Eastern District of Pennsylvania on,behalf ...s Period"). If you wish to discuss this action or...
...o help members get the care they need, HARTFORD, ...asier for members impacted by the fast-moving wild...ns and access employee assistance and,behavior hea...ny people have been evacuated from their homes and...
... A new Mayo Clinic study due to be presented at th...Genetics in San Diego this week shows that a chrom... methods in identifying chromosomal genetic abnorm...hood to respond to a given treatment. , Plasma c...
Other Medicine News:Health News:Brain's 'Reward Chemical' May Help Spur Obesity 2Health News:Digirad Reports 2007 Third-Quarter, Nine-Month Financial Results 2Health News:Digirad Reports 2007 Third-Quarter, Nine-Month Financial Results 3Health News:Digirad Reports 2007 Third-Quarter, Nine-Month Financial Results 4Health News:Digirad Reports 2007 Third-Quarter, Nine-Month Financial Results 5Health News:Digirad Reports 2007 Third-Quarter, Nine-Month Financial Results 6Health News:Digirad Reports 2007 Third-Quarter, Nine-Month Financial Results 7Health News:Digirad Reports 2007 Third-Quarter, Nine-Month Financial Results 8Health News:Digirad Reports 2007 Third-Quarter, Nine-Month Financial Results 9Health News:AZoOptics.com - The A to Z of Optics Launched By AZoNetwork 2Health News:Shareholder Class Action Filed Against Aetna Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP 2Health News:Shareholder Class Action Filed Against Aetna Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP 3Health News:Aetna Reminds Members Affected by California Wildfires Where to Call for Help 2Health News:Aetna Reminds Members Affected by California Wildfires Where to Call for Help 3Health News:Test gives insight into prognosis in patients with plasma cell malignancies, finds Mayo Clinic study 2
(Date:11/19/2009)...RDEE, Ireland, Nov. 19 Warner Chil...ing of its previously announced secondary offering...o the public of $22.25 per share. The selling sha...al Partners, DLJ Merchant Banking, J.P. Morgan Par...Partners, L.P., certain other institutional invest...
(Date:11/19/2009)... TAINAN, Taiwan, Nov. 19 /PRNewswire-Asia/ -- S...rmaceutical ingredients (APIs), announced that its...Safety Certification from,SafeBridge(R) Consultant...mpetency and proficiency in the safe handling of p...d applies to specific laboratories and,production ...
(Date:11/19/2009)...CAMBRIDGE, Mass., Nov. 19 Ligon Di...le microarray technology to find drugs against hig...d $1M in seed financing led by incTANK Ventures. T...itial discovery campaign that will screen over 100...estment, incTANK Ventures General Partner Christia...
Breaking Medicine Technology:Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3Finding the ZIP code for gene therapy 3A Scientists imitate viruses to deliver therapeutic genes 9739 1Finding the ZIP code for gene therapy 3A Scientists imitate viruses to deliver therapeutic genes 9739 2Moths cloaked in color 9737 1Moths cloaked in color 9737 2Moths cloaked in color 9737 3Moths cloaked in color 9737 4Beckman Coulter to Present at Upcoming Healthcare Conferences 13740 1Beckman Coulter to Present at Upcoming Healthcare Conferences 13740 2
...ity in Evaluating Drug,Efficacy; Dr. H. Bryan Brew...,PLEASANTON, CA, Mar 30, 2007 (MARKET WIRE via COM... LIPD) Dr. H. Bryan Brewer, Jr.,Chief Scientific ...he wide range of presentations at the recent Ameri...eans that the rationale for HDL,being the next, mo...
...ire-FirstCall/ --,Wyeth Pharmaceuticals, a divisio...beck A/S presented clinical study,results on bifep...ek. Safety analyses suggest bifeprunox, an investi...th schizophrenia, was,associated with a favorable ...ddition, increases in weight occurred in patients,...
Other Medicine Technology:Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 2Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 3Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 4Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 5Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 2Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 3Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 4Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 5Safety Analyses of Clinical Data for Bifeprunox in Patients with,Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar,to Placebo 6
Invertertube Surgical Microscope
...opper is designed for efficient division of hard a...for easy insertion through a micro incision and a ... nucleus. In addition, the tip is ideal for retri... be located peripherally inside the capsular bag. ...
MRI Compatible Syringe Pump
Safe-Cross RF System
Medicine Products: